BlackRock Inc. - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 73 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q2 2022. The put-call ratio across all filers is 1.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$4,018,302
-47.1%
1,400,105
-7.0%
0.00%
Q2 2023$7,602,468
+431.8%
1,505,439
+99.0%
0.00%
Q1 2023$1,429,571
-20.1%
756,387
-23.9%
0.00%
Q4 2022$1,788,785
-16.3%
993,769
-21.3%
0.00%
Q3 2022$2,136,000
-31.7%
1,263,517
-0.7%
0.00%
Q2 2022$3,129,000
-51.5%
1,272,112
-45.4%
0.00%
Q1 2022$6,452,000
-46.2%
2,329,164
+3.6%
0.00%
Q4 2021$11,985,000
-35.3%
2,248,467
+2.6%
0.00%
-100.0%
Q3 2021$18,533,000
-29.4%
2,190,630
+1.7%
0.00%0.0%
Q2 2021$26,259,000
-43.9%
2,154,212
+11.6%
0.00%0.0%
Q1 2021$46,837,000
-12.7%
1,930,585
+15.4%
0.00%
-50.0%
Q4 2020$53,624,000
+61.7%
1,673,138
+52.5%
0.00%
+100.0%
Q3 2020$33,172,000
+4.6%
1,097,320
+45.8%
0.00%0.0%
Q2 2020$31,720,000
+123.9%
752,368
+32.5%
0.00%0.0%
Q1 2020$14,164,000567,6880.00%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q2 2022
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders